EPO and chronic kidney disease: This mechanism would be similar to that previously presented for iron deficiency and EPO, with increased transcription and, at the same time, post-transcriptional excision, but which in situations with an alteration of this control, such as CKD, would give rise to increased iFGF23 [109].